drugset / Trial / NCT04214808
To Evaluate the Pharmacokinetics and Safety of AD-208
RandomizedCrossoverOpen-labelTreatment
Summary
To evaluate pharmacokinetics and safety of AD-208.
Timeline
- Start
- 2020-01-03
- Primary completion
- 2020-02-04
- Completion
- 2020-05-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dutasteride | Small molecule | 0.2 mg | — |
| Subject | Dutasteride | Small molecule | 0.5 mg | — |